Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma-Reference-Cited by-同舟云学术

Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma

Published:2024-06-20 Issue:15 Volume:19 Page:1389-1406
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Koula Gayathri¹²^ORCID,Yakati Venu¹²^ORCID,Rachamalla Hari Krishnareddy¹²^ORCID,Bhamidipati Keerti³²^ORCID,Kathirvel Muralidharan³^ORCID,Banerjee Rajkumar¹^ORCID,Puvvada Nagaprasad¹^ORCID

Affiliation:

1. Department of Oils, Lipids Sciences & Technology, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500007, India

2. Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, 201002, Uttar Pradesh (U.P), India

3. Applied Biology Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500007, India

Funder

DST, Government of India

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17435889.2024.2350357

Reference51 articles.

1. Epidemiologic and Molecular Prognostic Review of Glioblastoma

2. Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches

3. Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements

4. Clinical trial links oncolytic immunoactivation to survival in glioblastoma

5. Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma;Cancers;2024-08-27